Research Article
Utility of Endoscopic Examination in the Diagnosis of Acute Graft-versus-Host Disease in the Lower Gastrointestinal Tract
Table 2
Patient characteristics.
| Number | 186 | Average age, year (range) | 50.6 (19–82) | Gender | | Male | 122 | Female | 64 | Average inspection days after transplantation | | CS | 41.3 (13–100) | Average number of biopsy specimens | 4.9 | Primary disease | | Acute leukemia | 120 | Malignant lymphoma | 38 | Myelodysplastic syndrome | 16 | Chronic myelogenous leukemia | 5 | Others | 7 | Stem cell source | | Cord blood stem cell transplantation | 125 | Bone marrow transplantation | 36 | Alloperipheral blood stem cell transplantation | 25 | Previous treatment | | FLU-based regimen | 161 | CY/TBI or CY/BU | 25 | Preservation of GVHD | | FK + MMF | 72 | MTX + CyA/FK/MMF | 57 | CyA or FK | 57 | Extent of endoscopic insertion | | Up to the left-side colon | 15 | Until the right-side colon | 17 | Terminal ileum | 154 |
|
|
FLU: fludarabine; CY: cyclophosphamide; TBI: total body irradiation; BU: busulfan; CyA: cyclosporin A; MTX: methotrexate; MMF: mycophenolate mofetil.
|